13TSB_ENDANI: A pen side test for Schmallenberg virus exposure in sheep and cattle
13TSB_ENDANI: A pen side test for Schmallenberg virus exposure in sheep and cattle
批准号:
BB/L011387/1
负责人:
Janet Daly
金额:
$12.36万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project's primary objective is to develop a pen-side test for Schmallenberg virus (SBV) to a commercialisation stage.The test will be able to be used by Farmers and Veterinarians to determine whether an animal has been infected with SBV in a matter of minutes and at a greatly reduced cost to the existing tests performed by central laboratories. The project will use next generation phage-display technology to comprehensively screen serum from SBV infected animals for antibodies that react to the virus. The peptides on the virus that produce a robust antibody response in infected animals will be selected and manufactured for used as the antigen for the serological test. Lateral flow device tests based on these peptides will be developed by Forsite diagnostics who manufacture several of these types of tests currently. They will produce a small-scale production of these tests for comparison for sensitivity and specificity against the existing laboratory-based tests. These tests will then be field trialled for ease of use, performance in the field and likely use by a large veterinary practice group. A secondary aim of the project is the identification of which parts of the virus are important in generating a host immune response. This information will be created as a result of the initial screening and will be able to be used in the design of the next generation of vaccines and tests for this virus. The vaccine due to be released in 2013 is a crude killed virus preparation and it is unlikely that there will be any way to distinguish vaccinated from naturally infected animals. This is likely to be a future requirement for export to non-EU countries meaning there will be a need for more sophisticated vaccine and test strategies in the near future.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/s12917-015-0365-1
发表时间:
2015-03-11
期刊:
BMC veterinary research
影响因子:
2.6
作者:
[Daly JM, King B, Tarlinton RA, Gough KC, Maddison BC, Blowey R]
通讯作者:
Blowey R
Zika: Harnessing plant power for rational design of immunogens for use in diagnostic assays
-
批准号:MC_PC_15085
-
项目类别:Intramural
-
资助金额:$11.93万
-
财政年份:2016
-
负责人:Janet Daly
-
依托单位:
Application of next generation phage display technology to development of a Differentiation of Infected from Vaccinated Animals (DIVA) strategy
-
批准号:BB/M018822/1
-
项目类别:Research Grant
-
资助金额:$14.89万
-
财政年份:2015
-
负责人:Janet Daly
-
依托单位:
India Partnering Award: Collaboration on Diagnosis of Emerging Viruses (CoDEV)
-
批准号:BB/L026414/1
-
项目类别:Research Grant
-
资助金额:$3.52万
-
财政年份:2014
-
负责人:Janet Daly
-
依托单位:
国内基金
海外基金
登录
查看更多内容
环状RNA circ-PEN1通过编码蛋白PEN1-257aa调控拟南芥防御反应的机制研究
-
批准号:32370297
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李广林
-
依托单位:
PEN2调控OPC的增殖在脊髓损伤后轴突再髓鞘化过程中的作用及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:侯金星
-
依托单位:
神经元中的Pen-2缺失诱导脑微出血及其机制研究
-
批准号:82101388
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘婷婷
-
依托单位:
PEN-2蛋白:调控BCMA切割,提高抗BCMA CAR T细胞疗效新靶点?
-
批准号:82100221
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李丹
-
依托单位:
Pen2在成年神经元存活和大脑认知功能中的作用
-
批准号:31271123
-
项目类别:面上项目
-
资助金额:89.0万元
-
批准年份:2012
-
负责人:陈贵泉
-
依托单位:
PEN-2在Arf6导致的胰腺癌细胞黏附连接解体中的分子机制探讨
-
批准号:81101839
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:魏树梅
-
依托单位:
等离子混相喷射数字化制造高性能燃料电池的复杂形状复合功能模块
-
批准号:50675081
-
项目类别:面上项目
-
资助金额:26.0万元
-
批准年份:2006
-
负责人:王桂兰
-
依托单位:
早老素(PS1)在囊泡合成及转运中的调节功能研究
-
批准号:30572077
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2005
-
负责人:刘润中
-
依托单位: